| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Division of Critical Care Neurology, Neurological Institute, New York, NY.
We retrospectively reviewed the hospital records of 53 patients admitted for 73 episodes of myasthenic crisis at Columbia-Presbyterian Medical Center over a period of 12 years, from 1983 to 1994. Median age at the onset of first crisis was 55 (range, 20 to 82), the ratio of women to men was 21, and the median interval from onset of symptoms to first crisis was 8 months. Infection (usually pneumonia or upper respiratory infection) was the most common precipitating factor (38%), followed by no obvious cause (30%) and aspiration (10%). Twenty-five percent of patients were extubated at 7 days, 50% at 13 days, and 75% at 31 days; the longest crisis exceeded 5 months. Using survival analysis and backward stepwise Cox regression, we identified three independent predictors of prolonged intubation: (1) pre-intubation serum bicarbonate 
30 mg/dl (p = 0.0004, relative hazard 4.5), (2) peak vital capacity day 1 to 6 post-intubation <25 mYkg (p = 0.001, relative hazard 2.9), and (3) age >50 (p = 0.01, relative hazard 2.4). The proportion of patients intubated longer than 2 weeks was 0% among those with no risk factors, 21% with one risk factor, 46% with two risk factors, and 88% with three risk factors (p = 0.0004). Complications independently associated with prolonged intubation included atelectasis (p = 0.002), anemia treated with transfusion (p = 0.03), Clostridium diffcile infection (p = 0.011, and congestive heart failure (p = 0.03). Three episodes of crisis were fatal, for a mortality rate of 4% (3/73); four additional patients died after extubation. All seven deaths were due to overwhelming medical comorbidity. Over half of those who survived were functionally dependent (home or institutionalized) at discharge. In addition to prospective controlled studies of immuno-therapies, the prevention and treatment of medical complications offers the best opportunity for further improving the outcome of myasthenic crisis.
This article has been cited by other articles:
|
|
 |
|
  A. Alshekhlee, J. D. Miles, B. Katirji, D. C. Preston, and H. J. Kaminski Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals Neurology, May 5, 2009; 72(18): 1548 - 1554. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. El-Bawab, W. Hajjar, M. Rafay, A. Bamousa, A. Khalil, and K. Al-Kattan Plasmapheresis before thymectomy in myasthenia gravis: routine versus selective protocols Eur. J. Cardiothorac. Surg., March 1, 2009; 35(3): 392 - 397. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bijulal, S. Harikrishnan, N. Namboodiri, V. K Ajitkumar, D. Gupta, and P S Mathuranath Tako-tsubo cardiomyopathy in a patient with myasthenia gravis crisis: a rare clinical association BMJ Case Reports, February 16, 2009; 2009(feb04_1): bcr0620080182 - bcr0620080182. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Chaudhuri and P.O. Behan Myasthenic crisis QJM, February 1, 2009; 102(2): 97 - 107. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Seneviratne, J. Mandrekar, E. F. M. Wijdicks, and A. A. Rabinstein Predictors of Extubation Failure in Myasthenic Crisis Arch Neurol, July 1, 2008; 65(7): 929 - 933. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Seneviratne, J. Mandrekar, E. F. M. Wijdicks, and A. A. Rabinstein Noninvasive Ventilation in Myasthenic Crisis Arch Neurol, January 1, 2008; 65(1): 54 - 58. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Yu, J. Li, S. Ma, J. Jiang, T. Wang, Z. Gamliel, Y. Jing, X. Zhang, and M. J. Krasna Different Characteristics of Nonthymomatous Generalized Myasthenia Gravis With and Without Oropharyngeal Involvement Ann. Thorac. Surg., November 1, 2007; 84(5): 1694 - 1698. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Deymeer, O. Gungor-Tuncer, V. Yilmaz, Y. Parman, P. Serdaroglu, C. Ozdemir, A. Vincent, and G. Saruhan-Direskeneli Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis Neurology, February 20, 2007; 68(8): 609 - 611. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J F Owe, A K Daltveit, and N E Gilhus Causes of death among patients with myasthenia gravis in Norway between 1951 and 2001 J. Neurol. Neurosurg. Psychiatry, February 1, 2006; 77(2): 203 - 207. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Natarajan and R. Weinstein Therapeutic Apheresis in Neurology Critical Care J Intensive Care Med, July 1, 2005; 20(4): 212 - 225. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Watanabe, T. Watanabe, T. Obama, T. Mawatari, H. Ohsawa, Y. Ichimiya, N. Takahashi, K. Kusajima, and T. Abe Prognostic factors for myasthenic crisis after transsternal thymectomy in patients with myasthenia gravis J. Thorac. Cardiovasc. Surg., March 1, 2004; 127(3): 868 - 876. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Laghi and M. J. Tobin Disorders of the Respiratory Muscles Am. J. Respir. Crit. Care Med., July 1, 2003; 168(1): 10 - 48. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Rabinstein and E. F.M. Wijdicks BiPAP in acute respiratory failure due to myasthenic crisis may prevent intubation Neurology, November 26, 2002; 59(10): 1647 - 1649. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. PROVENCIO, T. P. BLECK, and A. F. CONNORS Jr. Critical Care Neurology Am. J. Respir. Crit. Care Med., August 1, 2001; 164(3): 341 - 345. [Full Text] [PDF]
|
|
|
|
|
|
U. A. Zifko, M. W. Nicolle, W. Grisold, and C. F. Bolton Repetitive phrenic nerve stimulation in myasthenia gravis Neurology, September 1, 1999; 53(5): 1083 - 1083. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. I. Qureshi, M. A. Choudhry, M. S. Akbar, Y. Mohammad, H. C. Chua, A. M. Yahia, J. A. Ulatowski, D. A. Krendel, and R. T. Leshner Plasma exchange versus intravenous immunoglobulin treatment in myasthenic crisis Neurology, February 1, 1999; 52(3): 629 - 629. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
